These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

440 related articles for article (PubMed ID: 21494268)

  • 21. CP-481,715, a potent and selective CCR1 antagonist with potential therapeutic implications for inflammatory diseases.
    Gladue RP; Tylaska LA; Brissette WH; Lira PD; Kath JC; Poss CS; Brown MF; Paradis TJ; Conklyn MJ; Ogborne KT; McGlynn MA; Lillie BM; DiRico AP; Mairs EN; McElroy EB; Martin WH; Stock IA; Shepard RM; Showell HJ; Neote K
    J Biol Chem; 2003 Oct; 278(42):40473-80. PubMed ID: 12909630
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Chemokine receptors as specific anti-inflammatory targets in peripheral nerves.
    Ubogu EE
    Endocr Metab Immune Disord Drug Targets; 2011 Jun; 11(2):141-53. PubMed ID: 21476965
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Chemokines as novel therapeutic targets in inflammatory diseases.
    Ajuebor MN; Swain MG; Perretti M
    Biochem Pharmacol; 2002 Apr; 63(7):1191-6. PubMed ID: 11960595
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Chemokines and chemokine receptors in renal transplantation--from bench to bedside.
    Fischereder M
    Acta Physiol Hung; 2007 Mar; 94(1-2):67-81. PubMed ID: 17444276
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Treatment of experimental autoimmune encephalomyelitis with the chemokine receptor antagonist Met-RANTES.
    Matsui M; Weaver J; Proudfoot AE; Wujek JR; Wei T; Richer E; Trapp BD; Rao A; Ransohoff RM
    J Neuroimmunol; 2002 Jul; 128(1-2):16-22. PubMed ID: 12098506
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The chemokine family. Potential therapeutic targets from allergy to HIV infection.
    Proudfoot AE
    Eur J Dermatol; 1998; 8(3):147-57. PubMed ID: 9649701
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Chemokines and their receptors: drug targets in immunity and inflammation.
    Viola A; Luster AD
    Annu Rev Pharmacol Toxicol; 2008; 48():171-97. PubMed ID: 17883327
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Endothelial chemokines in autoimmune disease.
    Christopherson KW; Hromas RA
    Curr Pharm Des; 2004; 10(2):145-54. PubMed ID: 14754394
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacological intervention at CCR1 and CCR5 as an approach for cancer: help or hindrance.
    Karash A; Mazzoni MR; Gilchrist A
    Curr Top Med Chem; 2014; 14(13):1553-73. PubMed ID: 25159162
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Multifunctional Role of the Chemokine System in Arthritogenic Processes.
    Bernardini G; Benigni G; Scrivo R; Valesini G; Santoni A
    Curr Rheumatol Rep; 2017 Mar; 19(3):11. PubMed ID: 28265846
    [TBL] [Abstract][Full Text] [Related]  

  • 31. MIP-1alpha[CCL3] acting on the CCR1 receptor mediates neutrophil migration in immune inflammation via sequential release of TNF-alpha and LTB4.
    Ramos CD; Canetti C; Souto JT; Silva JS; Hogaboam CM; Ferreira SH; Cunha FQ
    J Leukoc Biol; 2005 Jul; 78(1):167-77. PubMed ID: 15831559
    [TBL] [Abstract][Full Text] [Related]  

  • 32. 17 beta-estradiol inhibits cytokine, chemokine, and chemokine receptor mRNA expression in the central nervous system of female mice with experimental autoimmune encephalomyelitis.
    Matejuk A; Adlard K; Zamora A; Silverman M; Vandenbark AA; Offner H
    J Neurosci Res; 2001 Sep; 65(6):529-42. PubMed ID: 11550221
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Chemokine and chemokine receptor expression in paired peripheral blood mononuclear cells and synovial tissue of patients with rheumatoid arthritis, osteoarthritis, and reactive arthritis.
    Haringman JJ; Smeets TJ; Reinders-Blankert P; Tak PP
    Ann Rheum Dis; 2006 Mar; 65(3):294-300. PubMed ID: 16107514
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Chemokine blockade and chronic inflammatory disease: proof of concept in patients with rheumatoid arthritis.
    Haringman JJ; Kraan MC; Smeets TJ; Zwinderman KH; Tak PP
    Ann Rheum Dis; 2003 Aug; 62(8):715-21. PubMed ID: 12860725
    [TBL] [Abstract][Full Text] [Related]  

  • 35. "Chemokine receptors as therapeutic targets: Why aren't there more drugs?".
    Solari R; Pease JE; Begg M
    Eur J Pharmacol; 2015 Jan; 746():363-7. PubMed ID: 25016087
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Molecular Pharmacology of Chemokine Receptors.
    de Wit RH; de Munnik SM; Leurs R; Vischer HF; Smit MJ
    Methods Enzymol; 2016; 570():457-515. PubMed ID: 26921959
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Chemokines.
    Horuk R
    ScientificWorldJournal; 2007 Feb; 7():224-32. PubMed ID: 17334613
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Chemokines and chemokine receptors in arthritis.
    Szekanecz Z; Vegvari A; Szabo Z; Koch AE
    Front Biosci (Schol Ed); 2010 Jan; 2(1):153-67. PubMed ID: 20036936
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Blockade of chemokines in chronic inflammatory diseases].
    Haringman JJ; Tak PP
    Ned Tijdschr Geneeskd; 2004 Sep; 148(36):1760-4. PubMed ID: 15495938
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Multi-faceted strategies to combat disease by interference with the chemokine system.
    Johnson Z; Schwarz M; Power CA; Wells TN; Proudfoot AE
    Trends Immunol; 2005 May; 26(5):268-74. PubMed ID: 15866240
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.